CLINICAL_TRIALS
trial_result
· 2019-09-04
Clinical Trial Update: The Peanut Oral Immunotherapy Study: Safety, Efficacy and Discovery [Phase 2]
Summary
Phase 2 trial assessing safety and efficacy of peanut oral immunotherapy in individuals with peanut allergy; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Stanford University | Conditions: Peanut Allergy | Phase 2 | Status: COMPLETED | Results posted: 2019-09-04